Found 163 matching trials
SIRT With Tremelimumab and Durvalumab for Resectable HCC PHASE1 The goal of this research study is to evaluate the safety and tolerability ...
Show More Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Learn More & Join Trial
Defining the Ablative Dose for Y-90 TARE PHASE2 This study is being done to help doctors improve how they treat liver tumor...
Show More Location
Northwestern University
Learn More & Join Trial
Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer PHASE1 This clinical trial will be conducted as a single-center, open-label, Phase...
Show More Location
University of Iowa Hospitals and Clinics
Learn More & Join Trial
Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases PHASE1 This is a phase I dose escalation study (3+3 design) with a dose expansion ...
Show More Location
University of California San Francisco
Learn More & Join Trial
Streamlining Radioembolization for Small HCC N/A In patients who has no sign suggesting high lung shunt fraction (TIPS, hepa...
Show More Location
National Cancer Center
Learn More & Join Trial
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres PHASE2 Neuroendocrine tumors (NETs) and cancers that originate from the gastrointe...
Show More Location
Rocky Mountain Cancer Center
Learn More & Join Trial
Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer PHASE1 The purpose of this study is to identify maximum tolerated dose (MTD), that...
Show More Location
Northwestern University
Learn More & Join Trial
CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases PHASE1 This is an open label fixed dose phase Ib of anti-CEA CAR-T cells hepatic a...
Show More Location
Roger Williams Medical Center
Learn More & Join Trial
Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery NA RATIONALE: Specialized internal radiation therapy that delivers a high dose...
Show More Location
Vanderbilt-Ingram Cancer Center
Learn More & Join Trial
Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma NA This is a prospective, single-blinded, single-arm, open-label Phase II tria...
Show More Location
University of California, San Francisco
Learn More & Join Trial